Author:
Lin Junli,Liu Youchen,Zhang Jiawei,Lu Ziqi,Guo Jianmin,Huang Yuankeng,Lin Baoqin,Yang Wei
Reference34 articles.
1. 25 years of proton pump inhibitors: a comprehensive review;Strand;Gut Liver,2017
2. A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects;Hassan-Alin;Eur. J. Clin. Pharmacol.,2005
3. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease;Lind;Aliment. Pharmacol. Ther.,2000
4. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study;Miner;Am. J. Gastroenterol.,2003
5. Stereoselective pharmacodynamics and pharmacokinetics of proton pump inhibitors;Yang;Curr. Drug Metab.,2016